CorVel Stock (NASDAQ:CRVL)


RevenueOwnershipFinancialsChart

Previous Close

$108.06

52W Range

$79.81 - $128.61

50D Avg

$111.70

200D Avg

$110.90

Market Cap

$5.43B

Avg Vol (3M)

$138.61K

Beta

1.02

Div Yield

-

CRVL Company Profile


CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

Show More

Industry

Insurance - Brokers

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

4,870

IPO Date

Jun 28, 1991

Website

CRVL Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 25Mar 24Mar 22
Patient Management Services$581.19M$530.00M$424.05M
Network Solutions Services$314.40M$265.32M$222.18M

Fiscal year ends in Mar 25 | Currency in USD

CRVL Financial Summary


Mar 25Mar 24Mar 23
Revenue$895.59M$795.31M$718.56M
Operating Income$120.82M$95.10M$59.43M
Net Income$95.17M$76.25M$66.36M
EBITDA$120.82M$121.35M$109.67M
Basic EPS$1.85$1.34$1.15
Diluted EPS$1.83$1.32$1.13

Fiscal year ends in Mar 25 | Currency in USD

Latest Earnings Call Transcripts


Q3 23Jan 30, 23 | 12:00 AM
Q2 23Nov 01, 22 | 12:00 AM
Q1 23Aug 02, 22 | 11:30 AM

Peer Comparison


TickerCompany
HUIZHuize Holding Limited
AJGArthur J. Gallagher & Co.
EHTHeHealth, Inc.
ERIEErie Indemnity Company
WTWWillis Towers Watson Public Limited Company
CRD-ACrawford & Company
BROBrown & Brown, Inc.